Autoantibodies against type I IFNs in patients with critical influenza pneumonia.
The Journal of experimental medicine, cilt.219, sa.11, 2022 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 219 Sayı: 11
- Basım Tarihi: 2022
- Doi Numarası: 10.1084/jem.20220514
- Dergi Adı: The Journal of experimental medicine
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE, Veterinary Science Database
- Bursa Uludağ Üniversitesi Adresli: Evet
Özet
In an international cohort of 279 patients with hypoxemic influenza pneumonia, we identified 13 patients (4.6%) with autoantibodies neutralizing IFN-alpha and/or -omega, which were previously reported to underlie 15% cases of life-threatening COVID-19 pneumonia and one third of severe adverse reactions to live-attenuated yellow fever vaccine.